Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial

Erin F Gillespie,Joanna C Yang,Noah J Mathis,Catherine B Marine,Charlie White,Zhigang Zhang,Christopher A Barker,Rupesh Kotecha,Alyson McIntosh,Max Vaynrub,Meredith K Bartelstein,Aaron Mitchell,David M Guttmann,Divya Yerramilli,Daniel S Higginson,Yoshida J Yamada,Zachary A Kohutek,Simon N Powell,Jillian Tsai,Jonathan T Yang,Erin F. Gillespie,Joanna C. Yang,Noah J. Mathis,Catherine B. Marine,Christopher A. Barker,Meredith K. Bartelstein,David M. Guttmann,Daniel S. Higginson,Yoshida J. Yamada,Zachary A. Kohutek,Simon N. Powell,Jonathan T. Yang
DOI: https://doi.org/10.1200/jco.23.00753
IF: 45.3
2023-09-26
Journal of Clinical Oncology
Abstract:In a multicenter RCT (n = 78), radiation to high-risk asymptomatic bone metastases ⬇ skeletal-related events and prolonged OS.
oncology
What problem does this paper attempt to address?